1. An overview of up and coming and existing therapies for SLE and LN
2. A review of recent advances in predictive factors of SLE / LN disease course
3. COVID 19 infection and vaccination implications in SLE

Please note that the personal information you provide will only be used for correspondence related to this survey. You may review GSK’s privacy notice to find out how GSK uses your personal information and your rights in relation to that information. To find out more you can paste the following link in the address bar of a web browser: https://privacy.gsk.com/en-ca/privacy-notice/healthcare-professional/